Vaccines: health systems are losing the game against pharmaceutical multinationals

2024-09-30 12:09:54

The doctor Luis Palòmo published a text entitled Doubt about vaccines in times of health cult in which he explains that all the news relating to vaccines (in general) only advantages are attributed, while reasonable doubts are rejected.

«It is labeled -Palomo writes- as deniers those who doubt and are ignored and people who hesitate official storypresumably scientific, on new vaccines or on any product marketed under the name of vaccine.

«It hasn’t always been like this. There was a time of consensus on effectiveness of vaccinations essential or systematic symptoms of childhood (poliomyelitis, diphtheria, tetanus, whooping cough, measles, rubella, mumps), because the relationship between benefits versus negative effects, inconveniences and costs “It was clearly above unity; in contrast, with some of the recently introduced vaccines it cannot be argued with such certainty that this ratio is clearly favorable.”

And to know the effectiveness of a vaccine it is not enough to obtain a high level of antibodies in the blood, because its epidemiological effect depends on the percentage of truly protected individuals among those vaccinated.

Human papilloma vaccine

And he gives examples of controversial vaccines such as, for example, human papillomavirus vaccine (VHP). In Spain, invasive cervical cancer is a rare diseasewith low mortality rates, and there is an effective detection test: the Pap smear.

The effectiveness of the vaccine is controversial because it does not prevent all cancer-related HPV serotypes, because the infection does not irremediably lead to cancer, because there is no certainty about the duration of the vaccine duration of immunity in the serotypes that compose it, because it could be there serious adverse effects in healthy girlseven deaths and permanent disabilities, when those same girls could live healthy and, if not vaccinated, undergo a safer and more effective Pap test in adulthood.

Furthermore, it can be dangerous for the false sense of security that the vaccine provides reduces the coverage of Pap test detection campaigns, which are much cheaper than the vaccine.

Therefore, “the inclusion of the HPV vaccine in the vaccination program was carried out without solid and unanimous evidence in its favor, amidst controversial scientific and professional statements. “It was an administrative decision on a preventive activity that is not worth what it costs, because it has not been proven to be sufficiently useful or sufficiently effective,” claims the doctor.

Currently there are still many doubts about its effectiveness (there are still cases in vaccinated women) and safety (neurological effect of the use of aluminum adjuvantsfor example) and on various pharmacological and commercial irregularities.

In other countries, such as Japan, the vaccine was withdrawn shortly after its introduction in 2013 due to parental complaints about the adverse effects observed. Nine years later it was reintroduced because more cases of invasive cervical cancer were seen in groups of unvaccinated girls.

Chickenpox vaccine

In 2015, when it was decided to introduce the chickenpox vaccineHim GRADE rated group studied mortality and hospitalizations for chickenpox and shingles in Navarra, Madrid, Ceuta and Melilla, where the vaccine had already been administered, comparing the rates with the rest of Spain. They found no statistically significant differences in none of the age groups analyzed between the pre-vaccine period (1999-2004) and the post-vaccine period (2005-2013) in any of the four variables studied.

In the same sense also some qualified technicians, like the now deceased Francisco Salmerónwarned that the introduction of the chickenpox vaccine was a more complex decision than it was intended to be at an administrative level; that the problem of herpes zoster had to be taken into account; that there was no evidence to be sure that vaccination in early childhood would not end up causing more serious problemssuch as the increase in chickenpox in adults, chickenpox in pregnant women and even a increase in herpes zoster in the population mayor.

Although the the incidence of herpes zoster is increasingthis increase is attributed to the aging of the population.

Vaccine against meningitis

Palomo says the decision to include the meningitis B vaccine in the vaccination program has been the subject of objections, because due to the relative low incidence of the disease, the questionable effectiveness over time of this vaccine and its high priceit didn’t seem logical to include it in the ordinary vaccination calendar, but it seemed logical to use it in a hospital manner for those people who, individually, due to immunodeficiency situations, needed it.

For example, the Spanish Society of Public Health and Health Administration (SESPAS) was in favor of limiting the meningitis B vaccine to risk groups because the inclusion of the meningitis B vaccine in the calendar of some Autonomous Communities seemed to be based on more typical of the political and scientific spheres. The aforementioned Salmerón denounced the grip of health policy and scientific societies regarding the pressure exerted by the industry marketing vaccines against chickenpox and meningitis B.

Synthetic viral “vaccine”.

Nirsevimab It is a monoclonal antibody, although it has been marketed since 2023 as if it were a monoclonal antibody vaccine against respiratory syncytial virus infection. The GRADE-Evalmed group analyzed the product trials and found that, out of 115 participating children: a) 113 would not be hospitalized for non-serious illnesses during the 80 days; b) 1 will have the event after 33 days in both groups; and c) 1 will avoid the event during 80 days in the nirsevimab group, while that 1 will suffer the event after 40 days in the no-intervention group.

As regards hospitalization for serious illness, out of 287 participating newborns: a) 285 will not take part in the event during the 80 days in both groups; b) 1 will have the event after 27 days in both groups; and c) 1 will avoid the event during 80 days in the nirsevimab group, while that 1 will suffer the event after 40 days in the no-intervention group. THE adverse effects were unfavorable for the nirsevimad group. The dose of the drug costs €209. “A balance that is not at all optimistic”, concludes the space scientist.

Vaccines against covid-19

And we arrived at vaccines against the SARS-Cov2 coronavirus on which in just four years millions of articles and different opinions have accumulated, so much so that it is “difficult to find a rational way to know the effectiveness of these vaccines”, says Palomo.

With the available data, it appears that the Natural immunity is superior to that acquired from vaccines. Furthermore, according to Fraiman, Erviti et al. a was detected excessive risk of serious adverse events in published clinical trials of RNA vaccines Pfizer and of Modernwhich highlights the need for formal risk and benefit analyses.

In the 28 days following vaccination with the Pfizer vaccine, there was an increased rate of episodes of acute coronary diseasecerebrovascular diseases and coagulation disorders. In the case of Moderna, the greatest risk occurred in cerebrovascular diseases and clotting disorders. The AstraZeneca vaccine presented increased risks in all types of disorders analyzed.

The known adverse effects are certainly very varied underestimated due to the lack of habit of communicating themdue to the underestimation of the risk by professionals and patients, or due to the temporal distance between the effect and the vaccination act, which makes it difficult to relate both events.

Finally, as this doctor explains, there are doubts about the relationship between vaccination against Covid-19 and excess mortality in the years 2021 and 2022. There are data that invite us to test this hypothesis. For example, in a report on the state of the MoMo system, from the National Center of Epidemiology of the Carlos III Institute of Health, which monitors excess mortality from all causes, one could compare two practically identical periods that include the months of August 2020 and 2021.

The 2020 period covers from 07/20/2020 to 08/29/2020. In this period an excess mortality of 10.5% was observed: 7.8% for men, 13.2% for women, 5.1% for < 65 years, 5.0% between 65-74 years and 12.7% for those over 74 years old. In the period of 2021 (from 07/19/2021 to 08/30/2021) the the excess mortality was significantly higher than that of the same period 2020 in all groups: 15.8% excess total mortality, 16.1% for men, 15.8% for women, 8.2% for < 65 years, 15.0% between 65-74 years and 17.9% for those over 74 years of age, the gap between the 2 periods being greater in the older ages (the 65-74 year age group stands out), where practically the entire population is vaccinated and a significant part of the weakest have died in 2020.

«Most developed countries have observed excess mortality from 2021in the UK, Germany and all countries included in EuroMOMO in the period 2019-2023. The most singular case is mortality in the 0 to 14 year age group, given that in 2021 and 2022 the deaths exceeding those expected were 719 and 1,168 respectively. The question is whether vaccines and administration dates can help explain this evolution”, concludes this professional, who concludes with an energetic paragraph:

«Los Health systems are losing the game against pharmaceutical multinationals. Health systems have not been strengthened to be able to rigorously evaluate new vaccines and their effectiveness in the field, they have even accepted vaccines based on methodologically deficient clinical studies in the case of vaccine against Covid-19but the pharmaceutical industry has consolidated its power by making technological innovations its own and imposing its conditions on scientific methodology, influence access to new drugs and multiplying their profits with vaccines.